BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11914644)

  • 21. The prognostic significance of thymidylate synthase and dihydropyrimidine dehydrogenase in colorectal cancer of 303 patients adjuvantly treated with 5-fluorouracil.
    Jensen SA; Vainer B; Sørensen JB
    Int J Cancer; 2007 Feb; 120(3):694-701. PubMed ID: 17096352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive value of thymidylate synthase expression in resected metastases of colorectal cancer.
    Corsi DC; Ciaparrone M; Zannoni G; Mancini M; Cassano A; Specchia M; Pozzo C; Martini M; Barone C
    Eur J Cancer; 2002 Mar; 38(4):527-34. PubMed ID: 11872345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relation between thymidylate synthase expression and survival in colon carcinoma, and determination of appropriate application of 5-fluorouracil by immunohistochemical method.
    Takenoue T; Nagawa H; Matsuda K; Fujii S; Nita ME; Hatano K; Kitayama J; Tsuruo T; Muto T
    Ann Surg Oncol; 2000 Apr; 7(3):193-8. PubMed ID: 10791849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of 5-fluorouracil metabolic enzyme genes in Dukes' stage B and C colorectal cancer patients treated with oral 5-fluorouracil-based adjuvant chemotherapy.
    Yamada H; Iinuma H; Watanabe T
    Oncol Rep; 2008 Mar; 19(3):729-35. PubMed ID: 18288408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The dissociated expression of protein and messenger RNA of DPC4 in human invasive ductal carcinoma of the pancreas and their implication for patient outcome.
    Toga T; Nio Y; Hashimoto K; Higami T; Maruyama R
    Anticancer Res; 2004; 24(2C):1173-8. PubMed ID: 15154643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative significance of p53 and WAF/1-p21 expression on the efficacy of adjuvant chemotherapy for resectable invasive ductal carcinoma of the pancreas.
    Nio Y; Dong M; Uegaki K; Hirahara N; Minari Y; Sasaki S; Takamura M; Iguchi C; Tamura K
    Pancreas; 1999 Mar; 18(2):117-26. PubMed ID: 10090408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thymidylate synthase expression in colorectal cancer: a prognostic and predictive marker of benefit from adjuvant fluorouracil-based chemotherapy.
    Edler D; Glimelius B; Hallström M; Jakobsen A; Johnston PG; Magnusson I; Ragnhammar P; Blomgren H
    J Clin Oncol; 2002 Apr; 20(7):1721-8. PubMed ID: 11919227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression and prognostic significance of thymidylate synthase (TS) in pancreatic head and periampullary cancer.
    van der Zee JA; van Eijck CH; Hop WC; van Dekken H; Dicheva BM; Seynhaeve AL; Koning GA; Eggermont AM; Ten Hagen TL
    Eur J Surg Oncol; 2012 Nov; 38(11):1058-64. PubMed ID: 22633450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical quantitation of thymidylate synthase expression in colorectal cancer metastases predicts for clinical outcome to fluorouracil-based chemotherapy.
    Aschele C; Debernardis D; Casazza S; Antonelli G; Tunesi G; Baldo C; Lionetto R; Maley F; Sobrero A
    J Clin Oncol; 1999 Jun; 17(6):1760-70. PubMed ID: 10561213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical evaluation of thymidylate synthase in gastric carcinoma using a new polyclonal antibody: the clinical role of thymidylate synthase as a prognostic indicator and its therapeutic usefulness.
    Kuniyasu T; Nakamura T; Tabuchi Y; Kuroda Y
    Cancer; 1998 Oct; 83(7):1300-6. PubMed ID: 9762929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thymidylate synthase expression and response to neoadjuvant chemotherapy in patients with advanced head and neck cancer.
    Johnston PG; Mick R; Recant W; Behan KA; Dolan ME; Ratain MJ; Beckmann E; Weichselbaum RR; Allegra CJ; Vokes EE
    J Natl Cancer Inst; 1997 Feb; 89(4):308-13. PubMed ID: 9048835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation between expression of thymidylate synthase and clinical outcome of advanced gastric cancer treated with capecitabine alone chemotherapy.
    Liu XF; Zhang H; Sun JQ; Yin C; Liu TF; Yang H; Chen LH
    Tumour Biol; 2014 Dec; 35(12):12409-14. PubMed ID: 25185651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunolocalization of thymidylate synthase as a favorable prognostic marker in estrogen receptor-positive breast carcinoma.
    Takagi K; Miki Y; Nakamura Y; Hirakawa H; Kakugawa Y; Amano G; Watanabe M; Ishida T; Sasano H; Suzuki T
    Histol Histopathol; 2015 Oct; 30(10):1223-32. PubMed ID: 25873048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thymidylate synthase predicts for clinical outcome in invasive breast cancer.
    Yu Z; Sun J; Zhen J; Zhang Q; Yang Q
    Histol Histopathol; 2005 Jul; 20(3):871-8. PubMed ID: 15944938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intratumoral expression of thymidylate synthase and dihydropyrimidine dehydrogenase in non-small cell lung cancer patients treated with 5-FU-based chemotherapy.
    Huang CL; Yokomise H; Kobayashi S; Fukushima M; Hitomi S; Wada H
    Int J Oncol; 2000 Jul; 17(1):47-54. PubMed ID: 10853017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacogenetic studies on the prediction of efficacy and toxicity of fluoropyrimidine-based adjuvant therapy in colorectal cancer].
    Kralovánszky J; Adleff V; Hitre E; Pap E; Réti A; Komlósi V; Budai B
    Magy Onkol; 2007; 51(2):113-25. PubMed ID: 17660867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase expression, and histological tumour regression after 5-FU-based neo-adjuvant chemoradiotherapy in rectal cancer.
    Jakob C; Aust DE; Meyer W; Baretton GB; Schwabe W; Häusler P; Becker H; Liersch T
    J Pathol; 2004 Dec; 204(5):562-8. PubMed ID: 15538739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic and predictive value of thymidylate synthase expression in primary colorectal cancer.
    Karlberg M; Ohrling K; Edler D; Hallström M; Ullén H; Ragnhammar P
    Anticancer Res; 2010 Feb; 30(2):645-51. PubMed ID: 20332484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of gastric and intestinal phenotypic marker expression of gastric carcinomas with tumor thymidylate synthase expression and response to postoperative chemotherapy with 5-fluorouracil.
    Tajima Y; Shimoda T; Nakanishi Y; Yokoyama N; Tanaka T; Shimizu K; Saito T; Kawamura M; Kusano M; Kumagai K
    J Cancer Res Clin Oncol; 2003 Dec; 129(12):683-90. PubMed ID: 14576935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Do thymidylate synthase gene promoter polymorphism and the C/G single nucleotide polymorphism predict effectiveness of adjuvant 5-fluorouracil-based chemotherapy in stage III colonic adenocarcinoma?
    Prall F; Ostwald C; Schiffmann L; Barten M
    Oncol Rep; 2007 Jul; 18(1):203-9. PubMed ID: 17549369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.